These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38250890)

  • 1. A Mixture of T-Cell Epitope Peptides Derived from Human Respiratory Syncytial Virus F Protein Conferred Protection in DR1-TCR Tg Mice.
    Guo H; Song Y; Li H; Hu H; Shi Y; Jiang J; Guo J; Cao L; Mao N; Zhang Y
    Vaccines (Basel); 2024 Jan; 12(1):. PubMed ID: 38250890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Respiratory Syncytial Virus F Glycoprotein Conformation on Induction of Protective Immune Responses.
    Palomo C; Mas V; Thom M; Vázquez M; Cano O; Terrón MC; Luque D; Taylor G; Melero JA
    J Virol; 2016 Jun; 90(11):5485-5498. PubMed ID: 27009962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice.
    Céspedes PF; Rey-Jurado E; Espinoza JA; Rivera CA; Canedo-Marroquín G; Bueno SM; Kalergis AM
    Vaccine; 2017 Feb; 35(5):757-766. PubMed ID: 28065474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal immunization with HRSV prefusion F protein and CpG adjuvant elicits robust protective effects in mice.
    Ren H; Li H; Cao L; Wang Z; Zhou Y; Guo J; Zhang Y; Liu H; Xu W
    Vaccine; 2022 Nov; 40(47):6830-6838. PubMed ID: 36253219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8+ T cell immunity against human respiratory syncytial virus.
    Rossey I; Sedeyn K; De Baets S; Schepens B; Saelens X
    Vaccine; 2014 Oct; 32(46):6130-7. PubMed ID: 25223272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus.
    Díaz FE; Guerra-Maupome M; McDonald PO; Rivera-Pérez D; Kalergis AM; McGill JL
    Front Immunol; 2021; 12():664212. PubMed ID: 33981309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired immune response to vaccination against infection with human respiratory syncytial virus at advanced age.
    Guichelaar T; Hoeboer J; Widjojoatmodjo MN; Reemers SS; van Els CA; Otten R; van Remmerden Y; Boes J; Luytjes W
    J Virol; 2014 Sep; 88(17):9744-50. PubMed ID: 24920795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel recombinant DNA vaccine candidates for human respiratory syncytial virus: Preclinical evaluation of immunogenicity and protection efficiency.
    Farrag MA; Amer HM; Öhlschläger P; Hamad ME; Almajhdi FN
    Hum Vaccin Immunother; 2017 Jul; 13(7):1586-1597. PubMed ID: 28272978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Synthetic SARS-CoV-2-Derived T-Cell and B-Cell Peptide Cocktail Elicits Full Protection against Lethal Omicron BA.1 Infection in H11-K18-hACE2 Mice.
    Song Y; Hu H; Xiao K; Huang X; Guo H; Shi Y; Zhao J; Zhu S; Ji T; Xia B; Jiang J; Cao L; Zhang Y; Zhang Y; Xu W
    Microbiol Spectr; 2023 Mar; 11(2):e0419422. PubMed ID: 36912685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TCR Repertoire Characterization for T Cells Expanded in Response to hRSV Infection in Mice Immunized with a Recombinant BCG Vaccine.
    Rey-Jurado E; Bohmwald K; Correa HG; Kalergis AM
    Viruses; 2020 Feb; 12(2):. PubMed ID: 32093256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models.
    Lambert SL; Aslam S; Stillman E; MacPhail M; Nelson C; Ro B; Sweetwood R; Lei YM; Woo JC; Tang RS
    PLoS One; 2015; 10(3):e0119509. PubMed ID: 25793508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naked DNA immunization with full-length attachment gene of human respiratory syncytial virus induces safe and protective immune response.
    Hamad ME; Amer HM; Farrag MA; Osman AH; Almajhdi FN
    Acta Virol; 2018; 62(2):137-146. PubMed ID: 29895154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein.
    Schepens B; Sedeyn K; Vande Ginste L; De Baets S; Schotsaert M; Roose K; Houspie L; Van Ranst M; Gilbert B; van Rooijen N; Fiers W; Piedra P; Saelens X
    EMBO Mol Med; 2014 Nov; 6(11):1436-54. PubMed ID: 25298406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RBF Protein with MA103 Adjuvant Elicited Protective Immunity against Human Respiratory Syncytial Virus in BALB/c Mice.
    Fang Q; Li H; Ren H; Cao L; Hu H; Zhang Y; Xu W
    Jpn J Infect Dis; 2023 May; 76(3):183-190. PubMed ID: 36724936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human respiratory syncytial virus F protein expressed in Pichia pastoris or Escherichia coli induces protective immunity without inducing enhanced respiratory disease in mice.
    Li H; Cao L; Zhang Y; Ren H; Zhao P; Xu W
    Arch Virol; 2020 May; 165(5):1057-1067. PubMed ID: 32144542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prefusion RSV F Immunization Elicits Th2-Mediated Lung Pathology in Mice When Formulated With a Th2 (but Not a Th1/Th2-Balanced) Adjuvant Despite Complete Viral Protection.
    Eichinger KM; Kosanovich JL; Gidwani SV; Zomback A; Lipp MA; Perkins TN; Oury TD; Petrovsky N; Marshall CP; Yondola MA; Empey KM
    Front Immunol; 2020; 11():1673. PubMed ID: 32849580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-neutralization of four paramyxoviruses by a human monoclonal antibody.
    Corti D; Bianchi S; Vanzetta F; Minola A; Perez L; Agatic G; Guarino B; Silacci C; Marcandalli J; Marsland BJ; Piralla A; Percivalle E; Sallusto F; Baldanti F; Lanzavecchia A
    Nature; 2013 Sep; 501(7467):439-43. PubMed ID: 23955151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoprotectivity of HLA-A2 CTL peptides derived from respiratory syncytial virus fusion protein in HLA-A2 transgenic mouse.
    Shao HY; Lin YW; Yu SL; Lin HY; Chitra E; Chang YC; Sia C; Chong P; Hsu MT; Wei OL; Chow YH
    PLoS One; 2011; 6(9):e25500. PubMed ID: 21980478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccine.
    Buchholz UJ; Granzow H; Schuldt K; Whitehead SS; Murphy BR; Collins PL
    J Virol; 2000 Feb; 74(3):1187-99. PubMed ID: 10627529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG ODN enhances the efficacy of F protein vaccine against respiratory syncytial virus infection in the upper respiratory tract via CD4
    Kawahara E; Yamamoto S; Shibata T; Hirai T; Yoshioka Y
    Biochem Biophys Res Commun; 2023 Dec; 686():149143. PubMed ID: 37926041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.